Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

Explore JNM’s collection of the most influential or frequently cited manuscripts in its 60-year history.

  • Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
  • 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
  • JNM Impact Factor 7.887
    The Journal of Nuclear Medicine has achieved the highest impact factor ever in its 60-year history, ranking fourth among all medical journals worldwide.
  • 1
  • 2
  • 3

Published Ahead of Print

  • You have access
    The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation
    Adam L. Kesner
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.260950; DOI: https://doi.org/10.2967/jnumed.120.260950
  • You have access
    Identification of a PET Radiotracer for Imaging of the Folate Receptor-alpha – A Potential Tool to Select Patients for Targeted Tumor Therapy
    Patrycja Guzik, Hsin-Yu Fang, Luisa M. Deberle, Martina Benesova, Susan Cohrs, Silvan D. Boss, Simon M. Ametamey, Roger Schibli and Cristina Mueller
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.255760; DOI: https://doi.org/10.2967/jnumed.120.255760
  • You have access
    Radioguided Surgery (Letter to the Editor)
    Giuliano Mariani, Renato A. Valdés Olmos, Sergi Vidal-Sicart and Harry William Strauss
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.261888; DOI: https://doi.org/10.2967/jnumed.120.261888
  • You have access
    HYPERMETABOLISM ON PEDIATRIC POSITRON EMISSION TOMOGRAPHY SCANS OF BRAIN GLUCOSE METABOLISM: What does it signify?
    HARRY T CHUGANI
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.256081; DOI: https://doi.org/10.2967/jnumed.120.256081
  • You have access
    Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis
    Julia Whitman, Isabel E Allen, Emily K. Bergsland, Insoo A. Suh and Thomas A. Hope
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.257303; DOI: https://doi.org/10.2967/jnumed.120.257303
  • You have access
    Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
    Mark C. Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, Martin G. Pomper, Kenneth J Pienta, Michael A Gorin, Emmanuel S Antonarakis, Samuel R. Denmeade and Steven P. Rowe
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.259226; DOI: https://doi.org/10.2967/jnumed.120.259226
View more published ahead of print articles

Featured Articles

  • 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine...
    January 19, 2021
  • Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate...
    January 19, 2021
  • The Solutions Come from Science and Knowledge
    January 19, 2021
  • Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval...
    January 19, 2021
  • 68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
    January 19, 2021

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

Current issue

Journal of Nuclear Medicine: 62 (2)
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
  • Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
  • Most Cited
  • Most Read
Loading
  • 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
  • 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
  • First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
  • Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
  • Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
More...
Back to top
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire